pipeline development – Talk Bio

Actionable Insights Powered by AI

Kyverna Therapeutics Cuts 16% of Staff in Q1 2025 Amid Pipeline Focus

3 weeks ago talkbio0Tagged Autoimmune Diseases, CAR-T, KYV-101, Kyverna, layoffs, pipeline development, Staff

Kyverna Therapeutics; layoffs; biotech; staff reduction; Q1 2025; CAR-T; autoimmune diseases; pipeline development; KYV-101

Sarepta Therapeutics: Next Steps After Full FDA Approval for Duchenne Muscular Dystrophy Gene Therapy

12 months ago talkbio0Tagged Ambulatory - qualifier value, Approved, Duchenne, ELEVIDYS, gene therapy, Genetic Medicine, Microdystrophin, pipeline development, Unable to walk (finding), United States Food and Drug Administration

Sarepta Therapeutics, Duchenne muscular dystrophy, gene therapy, FDA approval, Elevidys, microdystrophin, ambulatory patients, non-ambulatory patients, pipeline development, rare diseases, genetic medicine.